Mn Services Vermogensbeheer B.V. Eli Lilly & CO Transaction History

Mn Services Vermogensbeheer B.V.

$14.3 Billion
Q3 2024

A detailed history of Mn Services Vermogensbeheer B.V. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 311,988 shares of LLY stock, worth $234 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

311,988

Previous 318,888 2.16%

Holding current value

$234 Million

Previous $289 Million 4.26%

% of portfolio

1.94%

Previous 2.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $5.33 Million - $6.62 Million	-6,900 Reduced 2.16%	311,988 $276 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $5.58 Million - $7 Million	-7,700 Reduced 2.36%	318,888 $289 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $10.7 Million - $14.3 Million	-18,100 Reduced 5.25%	326,588 $254 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $4.57 Million - $5.39 Million	-8,700 Reduced 2.46%	344,688 $201 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $2.17 Million - $3 Million	5,000 Added 1.44%	353,388 $190 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $19.4 Million - $25.9 Million	-55,200 Reduced 13.68%	348,388 $163 Million
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $4.6 Million - $5.4 Million	14,800 Added 3.81%	403,588 $139 Million
Q4 2022 Feb 03, 2023	SELL	$321.55 - $374.67 $19.5 Million - $22.7 Million	-60,500 Reduced 13.47%	388,788 $142 Million
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $8.33 Million - $9.49 Million	-28,100 Reduced 5.89%	449,288 $145 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $29.7 Million - $34.9 Million	-106,500 Reduced 18.24%	477,388 $155 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $8.89 Million - $11.1 Million	-37,900 Reduced 6.1%	583,888 $167 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $3.04 Million - $3.77 Million	13,500 Added 2.22%	621,788 $172 Million
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $2.42 Million - $2.97 Million	10,900 Added 1.82%	608,288 $141 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $28.9 Million - $37.4 Million	-160,200 Reduced 21.15%	597,388 $116 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $1.23 Million - $1.62 Million	9,400 Added 1.26%	757,588 $128 Million
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $2.16 Million - $2.5 Million	14,800 Added 2.02%	748,188 $111 Million
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $4.46 Million - $5.37 Million	-32,700 Reduced 4.27%	733,388 $120 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $5.61 Million - $6.94 Million	-47,100 Reduced 5.79%	766,088 $106 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $2.92 Million - $3.62 Million	27,300 Added 3.47%	813,188 $107 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $35 Million - $38.1 Million	327,644 Added 71.5%	785,888 $87.9 Million
Q2 2019 Jul 25, 2019	SELL	$110.79 - $129.32 $5.44 Million - $6.35 Million	-49,100 Reduced 9.68%	458,244 $50.8 Million
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $3.62 Million - $4.26 Million	-32,539 Reduced 6.03%	507,344 $65.8 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $40.7 Million - $45.6 Million	384,027 Added 246.4%	539,883 $54.7 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $103,893 - $122,639	1,400 Added 0.91%	155,856 $12.1 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $762,042 - $817,377	-9,300 Reduced 5.68%	154,456 $10.9 Million
Q3 2017 Nov 01, 2017	BUY	$77.07 - $85.54 $12.6 Million - $14 Million	163,756	163,756 $14 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account

Mn Services Vermogensbeheer B.V. Eli Lilly & CO Transaction History